NTRB
Nutriband Inc

2,366
Mkt Cap
$52.84M
Volume
11.00
52W High
$9.34
52W Low
$3.61
PE Ratio
-1.42
NTRB Fundamentals
Price
$4.43
Prev Close
$4.34
Open
$4.33
50D MA
$4.52
Beta
0.77
Avg. Volume
18,231.40
EPS (Annual)
-$0.9882
P/B
6.99
$83.81
Loading...
Loading...
News
all
press releases
Nutriband (NASDAQ:NTRB) Trading 2.3% Higher - Here's What Happened
Nutriband (NASDAQ:NTRB) Trading Up 2.3% - Here's What Happened...
MarketBeat·14d ago
News Placeholder
More News
News Placeholder
Short Interest in Nutriband Inc. (NASDAQ:NTRB) Grows By 22.7%
Nutriband Inc. (NASDAQ:NTRB - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 15th, there was short interest totaling...
MarketBeat·2mo ago
News Placeholder
What's Going On With Nutriband Stock Monday?
Nutriband shares are trading higher Monday after the company it signed an agreement to sell the majority stake of its subsidiary, Pocono Pharmaceutical, to EarthVision Bio.read more...
Benzinga·2mo ago
News Placeholder
What’s Driving Nutriband Shares Higher Today?
Nutriband has agreed to sell 90% of its stake in its subsidiary Pocono Pharmaceuticals for $5 million.
Stocktwits·2mo ago
News Placeholder
Nutriband (NASDAQ:NTRB) Announces Earnings Results
Nutriband (NASDAQ:NTRB - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.32) EPS for the quarter, beating the consensus estimate of ($2.13) by $1.81. The business...
MarketBeat·2mo ago
News Placeholder
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of +70.37% and -15.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Nutriband (NASDAQ:NTRB) Rating Increased to Hold at Zacks Research
Zacks Research raised Nutriband from a "strong sell" rating to a "hold" rating in a report on Tuesday...
MarketBeat·3mo ago
News Placeholder
TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates
TELA Bio (TELA) delivered earnings and revenue surprises of -11.76% and -5.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates
Korro Bio, Inc. (KRRO) delivered earnings and revenue surprises of +26.44% and -27.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Metagenomi (MGX) Reports Q3 Loss, Lags Revenue Estimates
Metagenomi (MGX) delivered earnings and revenue surprises of +8.33% and -6.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
<
1
2
...
>

Latest NTRB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.